- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 339/04 - Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
Patent holdings for IPC class C07D 339/04
Total number of patents in this class: 152
10-year publication summary
|
10
|
9
|
6
|
9
|
10
|
15
|
8
|
5
|
11
|
6
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Cellix Bio Private Limited | 52 |
9 |
| Exerkine Corporation | 35 |
7 |
| Research Foundation of the City University of New York | 424 |
6 |
| Cellixbio Private Limited | 152 |
5 |
| The Government of the United States of America, as represented by the Secretary of the Navy | 1367 |
5 |
| Novartis AG | 10595 |
4 |
| Ischemix LLC | 16 |
4 |
| Krisani Biosciences (P) Ltd | 7 |
4 |
| Antibe Therapeutics Inc. | 24 |
3 |
| Indigene Pharmaceuticals, Inc. | 9 |
3 |
| Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. | 59 |
3 |
| NeoStrata Company, Inc. | 11 |
3 |
| Nou-life Sciences, Inc. | 3 |
3 |
| Prous Institute for Biomedical Research, S.A. | 8 |
3 |
| Santen Pharmaceutical Co., Ltd. | 598 |
3 |
| Mitorx Therapeutics Limited | 5 |
3 |
| The United States of America as represented by the Secretary of the Navy | 2805 |
2 |
| The General Hospital Corporation | 4803 |
2 |
| Alnylam Pharmaceuticals, Inc. | 1143 |
2 |
| Cedars-Sinai Medical Center | 1178 |
2 |
| Other owners | 76 |